Bayesian Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,275	Closed	-$638K	–	162
2025 Q3	$638K	Buy	+2,275	New	+$619K	0.13%	233
2024 Q4	–	Sell	-2,262	Closed	-$757K	–	703
2024 Q3	$757K	Sell	2,262 -1,000	-31%	-$318K	0.09%	286
2024 Q2	$891K	Buy	+3,262	New	+$949K	0.1%	256
2023 Q4	–	Sell	-7,568	Closed	-$2.71M	–	760
2023 Q3	$2.71M	Buy	+7,568	New	+$2.92M	0.31%	87
2020 Q1	–	Sell	-3,004	Closed	-$1.11M	–	780
2019 Q4	$1.11M	Sell	3,004 -3,300	-52%	-$1.16M	0.19%	162
2019 Q3	$2.1M	Sell	6,304 -2,000	-24%	-$652K	0.4%	60
2019 Q2	$2.6M	Buy	8,304 +4,700	+130%	+$1.41M	0.54%	41
2019 Q1	$1.1M	Buy	3,604 +900	+33%	+$243K	0.21%	147
2018 Q4	$628K	Sell	2,704 -2,278	-46%	-$611K	0.13%	237
2018 Q3	$1.56M	Buy	4,982 +3,000	+151%	+$931K	0.26%	100
2018 Q2	$572K	Buy	1,982 +844	+74%	+$233K	0.13%	232
2018 Q1	$285K	Sell	1,138 -3,315	-74%	-$844K	0.07%	409
2017 Q4	$1.06M	Buy	+4,453	New	+$1.08M	0.22%	158
2017 Q1	–	Sell	-3,563	Closed	-$649K	–	418
2016 Q4	$649K	Buy	+3,563	New	+$607K	0.16%	244